by | Jun 1, 2019 | Briefings, EPO
A recent case from the EPO Boards of Appeal, T 0725/14, sees the Board consider again the issue of priority entitlement and what constitutes a valid transfer of priority rights. Of course, it is not the first time these issues have been considered but where this case...
by Alex Bajjon | May 1, 2019 | Briefings, UK
Background The patent in question (EP 1173181) related to a new dosage regime for tadalafil (marketed under the brand name Cialis®) for treating erectile dysfunction (ED). The patent is owned by ICOS and exclusively licensed to Eli Lilly. The claims of the patent...
by Sean Hughes | May 1, 2019 | Briefings, EPO
Background As previously reported, in G 2/12 (Broccoli and Tomatoes II), the Enlarged Board of Appeal found that Article 53(b) EPC did not exclude plants produced by essentially biological processes from patentability. Nevertheless, following guidance from the...
by Carolyn Haywood | May 1, 2019 | Briefings, EPO
The Broad Institute (Broad) manages a patent portfolio on behalf of several collaborating institutions, including Broad, Massachusetts Institute of Technology (MIT), and President and Fellows of Harvard College (Harvard) which contains several European patents for...
by | May 1, 2019 | Blog, News
“South coast patent attorney firm Schlich Ltd is living proof that you don’t need to be located in London to be take centre stage in some of the hottest European patent debates. The “meticulous, highly responsive and pleasant” side has been instrumental in the CRISPR...
Recent Comments